Moderna Is Expecting Massive Growth Over the Next Decade. Is the Stock a No-Brainer Buy?The Motley Fool • 09/22/23
With New COVID-19 Boosters in Tow, Which Is the Better Buy: Pfizer, BioNtech, or Moderna Stock?The Motley Fool • 09/20/23
UMass Chan Medical School and Moderna launch CMV TransmIT—a CareEvolution MyDataHelps-powered study for cytomegalovirus (CMV) transmission in the communityBusiness Wire • 09/19/23
Moderna (MRNA) Surges 3.2%: Is This an Indication of Further Gains?Zacks Investment Research • 09/14/23
EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's Updated Covid-19 Vaccine in The European UnionAccesswire • 09/14/23